Nexalin Technology, Inc. (NXL) vs Beyond Air, Inc. (XAIR)
Nexalin Technology, Inc. and Beyond Air, Inc. are both Medical Devices companies. Nexalin Technology, Inc. is the larger, with a market value of $3.6M against $3.1M — 1.1× the size. Beyond Air, Inc. grew revenue faster over the last twelve months: 60.8% against 24.3%. Beyond Air, Inc. has the higher net margin (−435.7% vs −4,138.5%) and the higher return on invested capital (−174.9% vs −1,108.8%). Across the 18 metrics below, Beyond Air, Inc. leads on 12 and Nexalin Technology, Inc. on 6.
Valuation
Profitability
| Metric | NXL | XAIR | Medical Devices median |
|---|---|---|---|
| Gross margin | 86.14% | 4.18% | 56.01% |
| Operating margin | (4,201.66%) | (364.76%) | (15.03%) |
| Net margin | (4,138.49%) | (435.71%) | (20.40%) |
| Free cash flow margin | (2,917.96%) | (254.96%) | (7.24%) |
| Return on equity | (240.25%) | (505.67%) | (15.32%) |
| Return on assets | (187.89%) | (109.80%) | (19.72%) |
| Return on invested capital | (1,108.82%) | (174.89%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack